Short-Term Glycemic Outcomes Associated with Imeglimin Use Among Patients with Type 2 Diabetes Mellitus: A Prospective Observational Study.

Drug Des Devel Ther · 2026 · PMC13390670 · PMID 42487877

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

Overall, while the findings suggest a favorable trend, the magnitude of benefit appears modest, and the clinical significance of these changes should be interpreted with caution.

also in 1,335 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.